期刊
DIABETES-METABOLISM RESEARCH AND REVIEWS
卷 27, 期 3, 页码 269-276出版社
WILEY
DOI: 10.1002/dmrr.1170
关键词
gestational diabetes; inflammation; CRP; amyloid A; pregnancy
资金
- Heart Research Foundation
- Aarne Koskelo Foundation
- Maire Taponen Foundation
- Finnish Medical Funding
- Jorvi Hospital Research Funding
- Biomedicum Foundation
- Special Government Funding of Finland [T1030A0087]
Background Gestational diabetes is a prediabetic state. Sub-clinical inflammation may play a role in the transition from gestational diabetes to type 2 diabetes; the role of the autonomic nervous system as a mediating system has been raised. We aimed to study the association of the sympathetic nervous system and sub-clinical inflammation in women with gestational diabetes. Methods We studied 41 Caucasian women with gestational diabetes and 22 healthy pregnant and 14 non-pregnant controls. We assayed plasma noradrenaline, insulin, C-reactive protein, interleukin-6, insulin growth factor-1, serum amyloid A, steroid hormone-binding globulin, alpha-1 acid glycoprotein and cortisol at 2400, 0400 and 0700 h. Results No differences existed in the concentrations of inflammatory markers between gestational diabetes and normal pregnancy but women with gestational diabetes showed loss of variation in C-reactive protein and serum amyloid A. Levels of hormone-binding globulin were lower in hypertensive compared with normotensive women with gestational diabetes at all time points and lowest at midnight when alpha-1 acid glycoprotein levels were higher in hypertensive women. Conclusions Gestational diabetes is associated with loss of natural variation of C-reactive protein and serum amyloid A, suggesting altered modulation of inflammation. Hypertension in gestational diabetes seems not to be associated with higher levels of inflammatory markers other than alpha-1 acid glycoprotein. Copyright (c) 2011 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据